LH Quote, Financials, Valuation and Earnings

Danaher has a net margin of 4.31% compared to Labcorp Holdings's net margin of 16.61%. Labcorp Holdings's return on equity of 9.29% beat Danaher's return on equity of 7.57%.

Labcorp Holdings has a consensus price target of $273.67, signalling upside risk potential of 21.63%. On the other hand Danaher has an analysts' consensus of $264.48 which suggests that it could grow by 45.5%. Given that Danaher has higher upside potential than Labcorp Holdings, analysts believe Danaher is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.988, which suggesting that the stock is 1.19% less volatile than S&P 500. In comparison Danaher has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.413%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.28%. Danaher offers a yield of 0.62% to investors and pays a quarterly dividend of $0.32 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are smaller than Danaher quarterly revenues of $6.5B. Labcorp Holdings's net income of $143.4M is lower than Danaher's net income of $1.1B. Notably, Labcorp Holdings's price-to-earnings ratio is 25.51x while Danaher's PE ratio is 34.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.46x versus 5.61x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

Exact Sciences has a net margin of 4.31% compared to Labcorp Holdings's net margin of -121.19%. Labcorp Holdings's return on equity of 9.29% beat Exact Sciences's return on equity of -34.11%.

Labcorp Holdings has a consensus price target of $273.67, signalling upside risk potential of 21.63%. On the other hand Exact Sciences has an analysts' consensus of $68.47 which suggests that it could grow by 60.92%. Given that Exact Sciences has higher upside potential than Labcorp Holdings, analysts believe Exact Sciences is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.988, which suggesting that the stock is 1.19% less volatile than S&P 500. In comparison Exact Sciences has a beta of 1.136, suggesting its more volatile than the S&P 500 by 13.608%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.28%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Exact Sciences quarterly revenues of $713.4M. Labcorp Holdings's net income of $143.4M is higher than Exact Sciences's net income of -$864.6M. Notably, Labcorp Holdings's price-to-earnings ratio is 25.51x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.46x versus 2.84x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Illumina has a net margin of 4.31% compared to Labcorp Holdings's net margin of 16.94%. Labcorp Holdings's return on equity of 9.29% beat Illumina's return on equity of -35.09%.

Labcorp Holdings has a consensus price target of $273.67, signalling upside risk potential of 21.63%. On the other hand Illumina has an analysts' consensus of $129.24 which suggests that it could grow by 74.28%. Given that Illumina has higher upside potential than Labcorp Holdings, analysts believe Illumina is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.988, which suggesting that the stock is 1.19% less volatile than S&P 500. In comparison Illumina has a beta of 1.376, suggesting its more volatile than the S&P 500 by 37.551%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.28%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Illumina quarterly revenues of $1.1B. Labcorp Holdings's net income of $143.4M is lower than Illumina's net income of $187M. Notably, Labcorp Holdings's price-to-earnings ratio is 25.51x while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.46x versus 2.70x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

Waters has a net margin of 4.31% compared to Labcorp Holdings's net margin of 26.52%. Labcorp Holdings's return on equity of 9.29% beat Waters's return on equity of 43.99%.

Labcorp Holdings has a consensus price target of $273.67, signalling upside risk potential of 21.63%. On the other hand Waters has an analysts' consensus of $401.94 which suggests that it could grow by 23.7%. Given that Waters has higher upside potential than Labcorp Holdings, analysts believe Waters is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.988, which suggesting that the stock is 1.19% less volatile than S&P 500. In comparison Waters has a beta of 1.036, suggesting its more volatile than the S&P 500 by 3.583%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.28%. Waters offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Waters pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Waters quarterly revenues of $872.7M. Labcorp Holdings's net income of $143.4M is lower than Waters's net income of $231.4M. Notably, Labcorp Holdings's price-to-earnings ratio is 25.51x while Waters's PE ratio is 30.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.46x versus 6.54x for Waters. Usually stocks with elevated PS ratios are considered overvalued.